Correlation Between Precision BioSciences and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Precision BioSciences and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precision BioSciences and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precision BioSciences and Caribou Biosciences, you can compare the effects of market volatilities on Precision BioSciences and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precision BioSciences with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precision BioSciences and Caribou Biosciences.
Diversification Opportunities for Precision BioSciences and Caribou Biosciences
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Precision and Caribou is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Precision BioSciences and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Precision BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precision BioSciences are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Precision BioSciences i.e., Precision BioSciences and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Precision BioSciences and Caribou Biosciences
Given the investment horizon of 90 days Precision BioSciences is expected to generate 1.46 times more return on investment than Caribou Biosciences. However, Precision BioSciences is 1.46 times more volatile than Caribou Biosciences. It trades about 0.05 of its potential returns per unit of risk. Caribou Biosciences is currently generating about -0.18 per unit of risk. If you would invest 426.00 in Precision BioSciences on December 30, 2024 and sell it today you would earn a total of 44.00 from holding Precision BioSciences or generate 10.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Precision BioSciences vs. Caribou Biosciences
Performance |
Timeline |
Precision BioSciences |
Caribou Biosciences |
Precision BioSciences and Caribou Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Precision BioSciences and Caribou Biosciences
The main advantage of trading using opposite Precision BioSciences and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precision BioSciences position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.Precision BioSciences vs. X4 Pharmaceuticals | Precision BioSciences vs. Acumen Pharmaceuticals | Precision BioSciences vs. Inozyme Pharma | Precision BioSciences vs. Terns Pharmaceuticals |
Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |